Appointments and advancements for May 26, 2026

Endpoints NewsExclusive: Protuoso gets $9.5M to build the next hub-and-spoke antibody developer

PharmaVoiceCan a chaotic FDA still deliver on faster drug development?

FierceBiotechLilly inks deals to buy 3 vaccine developers for up to $3.8B as M&A spree continues

FierceBiotechFacing looming Xtandi patent cliff, Astellas pins hopes on more deals while still cutting costs

BioWorldAppointments and advancements for May 26, 2026

BioWorldFinancings for May 26, 2026

BioWorldIn the clinic for May 26, 2026

BioWorldOther news to note for May 26, 2026

BioWorldRegulatory actions for May 26, 2026

Endpoints NewsLilly to acquire three vaccine biotechs for up to $3.8B

Endpoints NewsAstellas’ five-year plan includes chasing record sales and cost cuts

BioPharma DiveSR One’s Simeon George on how China is rewriting biotech’s venture playbook